All HIV + Patients (n = 525) | HIV + LP (n = 452) | HIV + EP (n = 73) | OR (95% CI) | p value | |
---|---|---|---|---|---|
Men (n) | 381 (72.5%) | 319 (71.2%) | 60 (82.2%) | 0.59 (0.28–1.00) | 0.050 |
Age (mean, SD) | 46 (±9) | 46 (±8) | 43 (±10) | 1.03 (1.01–1.08) | 0.010 |
Current CD4 (n/microL) (median, IQR) | 590 (441–756) | 570 (423–729) | 750 (589–981) | 0.997 (0.996–0.998) | <0.001 |
Smoke | |||||
None | 318 (60.6%) | 282 (62.4%) | 36 (49.3%) | 1 (ref.) | – |
<10 cigs (moderate) | 76 (14.4%) | 63 (14.0%) | 13 (17.8%) | 0.61 (0.31–1.23) | 0.173 |
>10 cigs (intense) | 99 (18.9%) | 84 (18.6%) | 15 (20.6%) | 0.71 (0.37–1.37) | 0.311 |
Missing | 32 (6.1%) | 23 (5.1%) | 9 (12.3%) | Not included | |
BMI (kg/m2) (SD) | 24.7 (±4.7) | 24.7 (±4.7) | 24.8 (±4.7) | 0.99 (0.94–1.05) | 0.891 |
Waist circompherence (cm) (SD) | 89.1 (±12) | 89.2 (±12) | 88.6 (±12) | 1.08 (0.98–1.03) | 0.467 |
Lipodystrophy | |||||
No lipodystrophy | 184 (35.0%) | 144 (31.9%) | 40 (54.8%) | 1 (ref.) | – |
Lipoatrophy | 129 (24.6%) | 112 (25.0%) | 16 (21.9%) | 1.96 (1.04–3.68) | 0.036 |
Fat accumulation | 212 (40.4%) | 195 (43.1%) | 17 (23.3%) | 3.18 (1.73–5.84) | <0.001 |
Cardiovascular and metabolic | |||||
Triglycerides (mg/dL) (medican, IQR) | 142 (95–207) | 143 (96–209) | 127 (93–185) | 1.00 (0.99–1.00) | 0.494 |
Total cholesterol (mg/dL) (mean, SD) | 198 (±45) | 197 (±45) | 197 (±43) | 1.00 (0.99–1.00) | 0.929 |
HDL (mg/dL) (mean, SD) | 46 (±14) | 46 (±14) | 47 (±16) | 0.99 (0.98–1.00) | 0.645 |
LDL (mg/dL) (mean, SD) | 117 (±33) | 117 (±33) | 119 (±33) | 0.99 (0.99–1.00) | 0.710 |
Glucose (mg/dL) (mean, SD) | 94 (±19) | 95 (±21) | 90 (±10) | 1.03 (1.01–1.05) | 0.011 |
HOMA (median, IQR) | 2.4 (1.4–3.8) | 1.9 (1.2–2.9) | 1.9 (1.2–3.0) | 1.29 (1.09–1.54) | 0.003 |